2020年9月10-12日，由浙江省药学会生物制药专业委员会、浙江省海高会生物医药分会和生物制药稳定性论坛公众号共同主办的“2020生物制药稳定性论坛---助力生物药研发：解决生物制药研发和产业化过程中极具挑战的稳定性问题”在杭州召开。

来自国内外企业界、高校、监管部门等生物制药稳定性领域的知名专家、学者到会，进行了精彩的主题报告。

MFI作为ProteinSimple用于药物制剂优化开发中检测不溶性颗粒以及颗粒物形态分析的技术，备受客户推崇。

ProteinSimple作为ling先的生命科学仪器制造商和技术提供商，参加了本次盛会。

ProteinSimple大中华区应用技术经理杜颖颖博士在会上做了精彩报告：“生物药稳定性表征整体解决方案”。

PPT分享如下：

2020年10月24-25日，由生物制品圈、抗体圈共同主办的第三届抗体药产业发展大会在上海召开。

来自国内外著名抗体药物企业家、权威专家、知名学者、科技精英，行业协会和组织代表等共赴此次盛会，共同交流生物制药前沿技术和经验，探讨行业发展趋势。

ProteinSimple作为ling先的生命科学仪器制造商和技术提供商，参加了本次盛会。

ProteinSimple市场部苏倩博士在会上做了精彩报告：“生物大分子药物质量控制的创新技术”。

PPT分享如下：

Santa Clara, CA, July 18, 2011 Cell Biosciences, Inc. today announced that it has changed its name to ProteinSimple to clearly reflect the Company's core mission in protein research.

The Company's goal is simply to help researchers gain a better understanding of proteins and their role in disease. ProteinSimple's strategy is to power protein research by making it simpler and more quantitative, ultimately revealing new insights into the true nature of proteins.

Over the past 3 years, ProteinSimple has built a unique portfolio of protein analysis tools including systems for traditional protein imaging, systems to probe the structure and purity of protein based therapeutics and systems that provide fresh insight into protein signaling. Later this year, the Company will launch a revolutionary product that is expected to completely reinvent and automate the Western Blot the most widely used technique in protein analysis.

The company expects to generate over $40 million in revenue in 2011, and has grown significantly from $1 million in 2008. ProteinSimple has over 170 employees and more than 10,000 systems installed around the world. In the last 18 months, the Company has made 4 acquisitions in the protein analysis space and raised over $60 million in venture capital.

“We are all very excited about our new ProteinSimple identity,” commented Tim Harkness, President and CEO of ProteinSimple. “After a period of tremendous growth and change, we felt it was important to speak clearly to our customers about our vision and goals. ProteinSimple captures our entire value proposition and culture in a single word. The employees of ProteinSimple are fully committed to helping researchers gain a deeper understanding of proteins and to building a unique protein analysis pure-play.”

About ProteinSimple

ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. The Company's strategy is to power protein research by making it simpler and more quantitative, ultimately revealing new insights into the true nature of proteins. ProteinSimple has built a unique portfolio of protein analysis tools including systems for traditional protein imaging, systems to probe the structure and purity of protein based therapeutics and systems that provide fresh insight into protein signaling. ProteinSimple has over 170 employees, more than 10,000 systems installed around the world and is headquartered in Santa Clara, California. For more information, visit www.proteinsimple.com.